Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.850.940.760.60

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 0.85 based on Mar2023 Consolidated results.
Year Fixed Capital/Sales
Mar20230.85
Mar20220.94
Mar20210.76
Mar20200.60

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2023 0.85
-9.57
Mar2022 0.94
23.68
Mar2021 0.76
26.67
Mar2020 0.6 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,558.2 Cr -4.6% -16% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,467.0 Cr -4.9% -2.6% 54% Stock Analytics
CIPLA ₹119,470.0 Cr -0.1% 5% 57.6% Stock Analytics
DIVIS LABORATORIES ₹116,563.0 Cr 8.1% 9.1% 25.6% Stock Analytics
ZYDUS LIFESCIENCES ₹105,690.0 Cr -2.4% 10.8% 110% Stock Analytics
DR REDDYS LABORATORIES ₹99,351.1 Cr 1.4% -4.8% 30.2% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-4.6%

-16%

NA
SENSEX

1.7%

1.1%

21.3%


You may also like the below Video Courses